Meta Pixel
Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

News and Announcements

The Art of Pitching: Navigating the Use of “Disruptive” and “Revolutionary”

  • Published October 10, 2023 11:00PM UTC
  • Publisher Wholesale Investor
  • Categories Capital Raising Tips

In the dynamic world of startups and innovation, terms like “disruptive,” “revolutionary,” and “breakthrough” are often thrown around. But are these terms always accurate, or are they just buzzwords that sound impressive? Steve Torso, the CEO & Co-Founder of Wholesale Investor, delves into the nuances of these terms and their implications in the capital raising process.

YouTube player

The Desire to Stand Out

Every founder and innovator wants their product or service to be seen as unique, groundbreaking, and, yes, disruptive. They envision their offerings as game-changers that redefine industries, much like how electric vehicles are reshaping the automotive sector. However, the reality often differs from this vision.

The Pitfalls of Overclaiming

While it’s natural for founders to view their products as revolutionary, it’s crucial to ensure these claims are substantiated. Labeling a product as “disruptive” when it merely offers an alternative to existing solutions can be misleading. For instance, electric vehicles don’t just provide an alternative mode of transport; they challenge the very foundation of the petroleum industry, rendering traditional petrol stations obsolete.

Perception vs. Reality

Founders often see the vast potential of their products. They dream of being the next Elon Musk, revolutionising entire industries. However, from an investor’s perspective, terms like “world’s only” or “breakthrough” can be red flags. Investors often encounter multiple pitches claiming similar unique attributes. Thus, making unsubstantiated claims can lead to skepticism and missed opportunities.

Advice for Founders

Steve Torso advises founders to be cautious with their choice of words. While passion and belief in one’s product are essential, it’s equally crucial to present a realistic picture to potential investors. Avoid overusing terms like “disruptive” or “world’s only” unless they can be genuinely substantiated. Instead, focus on the tangible benefits, the actual market gap being addressed, and the real-world impact of the product or service.

Conclusion

In the competitive world of startups and capital raising, authenticity and clarity are paramount. While it’s tempting to label every innovation as “disruptive” or “revolutionary,” it’s essential to ensure these claims stand up to scrutiny. By presenting a balanced and realistic picture, founders can build trust with investors and pave the way for successful collaborations.

Capital Insights
Wholesale Investor and CapitalHQ Sign Exclusive Master Licence with inQ Innovation Global to Provide Access to India’s High-Growth Startup Market

Wholesale Investor and inQ Innovation have forged a strategic partnership, granting global investors direct access to India’s rapidly expanding innovation ecosystem. This exclusive three-year agreement leverages CapitalHQ’s technology to streamline fundraising for Indian startups and expand deal flow for WI’s 45,000-strong investor network, aligning with India’s 2030 Vision for economic growth and innovation.

Capital Insights
EBR Systems: Aussie Medtech Ready to Disrupt $3.6B Heart Failure Market with Leadless Pacemaker

Andrew Shute, Senior Vice President of Business Development at EBR Systems, is confident that his Australian medical device company is poised to make a significant impact on the global cardiac rhythm management market. The focus? A novel leadless pacemaker designed to revolutionise treatment for heart failure patients. After years of development and rigorous clinical trials, […]

Join over 45,000+ sophisticated investors

Join Now